Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer-Reference-Cited by-同舟云学术

Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer

Published:2023-06 Issue: Volume:212 Page:115536
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Ruixin Sun,Yifan Liu,Chuanlong Wu,Min Zhou,Hong Luo,Guoxiu Du,Zhengyang Liu,Yansha Sun,Yiwei Dong,Jingwen Su,Mingliang Fan,Bizhi Shi,Hua Jiang,Zonghai Li

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference48 articles.

1. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane [J];Buzdar;Cancer,2002

2. Mesothelin, a novel immunotherapy target for triple negative breast cancer [J];Tchou;Breast Cancer Res. Treat.,2012

3. Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways [J];Yu;Cancer Biol. Ther.,2008

4. Olaparib Suppresses MDSC Recruitment via SDF1alpha/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice [J];Sun;Mol. Ther.,2021

5. Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-kappaB/Icam1 signaling [J];Zhou;Mol. Ther.,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

2. GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma;Acta Pharmacologica Sinica;2024-05-15

3. Construction of a breast cancer predictive nomogram based on diverse cell death methods and reveal tumor microenvironment characterization;2024-05-14

4. CARs are sharpening their weapons;Journal for ImmunoTherapy of Cancer;2024-01

5. Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential;Cancers;2023-12-26